載入...

In Vivo Selection of Rifamycin-Resistant Clostridium difficile during Rifaximin Therapy

We report the selection of Clostridium difficile resistant to the rifamycin class of antibiotics in a patient within 32 h of receiving rifaximin for the treatment of recurrent C. difficile diarrhea. Resistance was associated with single nucleotide substitutions within rpoB.

Na minha lista:
書目詳細資料
Main Authors: Carman, Robert J., Boone, James H., Grover, Harish, Wickham, Kimberly N., Chen, Li
格式: Artigo
語言:Inglês
出版: American Society for Microbiology 2012
主題:
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC3486587/
https://ncbi.nlm.nih.gov/pubmed/22908175
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.00974-12
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!